Consumer Durables - Domestic Appliances · Founded 2008 · www.eurekaforbes.com · BSE 543482 · NSE EUREKAFORB · ISIN INE0KCE01017
No Notes Added Yet
Business
Eureka Forbes Ltd. is a leading Indian company primarily engaged in the manufacturing and direct sale of health and hygiene products. Its core business revolves around water purification (under the "Aquaguard" brand) and cleaning solutions (primarily "Euroclean" vacuum cleaners). The company employs a multi-channel business model, historically relying heavily on a vast direct sales network that provides home demonstrations and after-sales service. It also leverages retail stores, e-commerce platforms, and institutional sales to reach customers. The company generates revenue through the sale of its products, as well as recurring revenue from consumables (filters) and annual maintenance contracts.
Revenue Mix
The company's primary business segments are:
Water Purification: This is the dominant segment, driven by the iconic "Aquaguard" brand, offering various types of purifiers (RO, UV, UF, Gravity-based) for domestic and commercial use.
Cleaning Solutions: This segment includes "Euroclean" vacuum cleaners and related accessories.
Air Purifiers & Security Solutions: These are smaller segments contributing less to overall revenue.
While specific revenue contribution percentages are not publicly available in a granular format, Water Purification is understood to be the largest contributor to both revenue and profitability.
Industry
Eureka Forbes operates within the highly competitive Indian consumer durables and domestic appliances industry, specifically in the water purification and vacuum cleaner sub-segments. The water purification market is characterized by a mix of organized and unorganized players, with intense competition from other national brands like Kent RO, Hindustan Unilever's Pureit, Livpure, and numerous regional players. In vacuum cleaners, it competes with both domestic and international brands. Eureka Forbes holds a significant market share in the branded water purifier segment, often considered among the top players, largely due to its strong brand recall and extensive direct sales and service network built over decades.
MOAT
Brand Equity: "Aquaguard" is a household name in India, synonymous with water purification, enjoying high trust and recall among consumers. "Euroclean" also has established brand recognition.
Distribution & Service Network: Historically, Eureka Forbes built a vast direct sales force and an extensive after-sales service network across urban and semi-urban India. This unique last-mile reach and service capability for installation and maintenance create a significant barrier to entry for competitors.
Customer Relationships: The direct sales model fosters deeper customer relationships and provides valuable insights into consumer needs and preferences, leading to repeat purchases and loyalty for service and consumables.
Growth Drivers
Increasing Health Awareness: Growing consumer awareness about waterborne diseases and air pollution drives demand for purifiers.
Rising Disposable Incomes: Increasing affluence allows more households to afford branded health appliances.
Urbanization & Tier 2/3 Market Penetration: Expansion into smaller cities and towns, where penetration levels are lower, offers significant growth potential.
Product Innovation: Introduction of advanced purification technologies, smart features, and connected devices to cater to evolving consumer preferences.
Channel Diversification: Expanding presence in modern retail and e-commerce channels to complement the traditional direct selling model.
After-Sales Service & Consumables: Recurring revenue from filters and service contracts provides a stable growth avenue.
Risks
Intense Competition: Aggressive pricing and marketing by domestic and international rivals can impact market share and margins.
Dependency on Direct Sales: The traditional direct selling model can be high-cost, and optimizing its efficiency while expanding other channels is a challenge.
Technological Obsolescence: Rapid advancements in purification technology require continuous R&D investment to remain competitive.
Raw Material Price Volatility: Fluctuations in prices of components and raw materials can impact manufacturing costs and profitability.
Economic Slowdown: As discretionary products, demand can be impacted during periods of economic downturn or reduced consumer spending.
Regulatory Changes: Evolving regulations regarding water quality standards or product safety could necessitate significant compliance costs.
Management & Ownership
Eureka Forbes Ltd. became a standalone listed entity following its demerger from Forbes & Company Ltd. and subsequent acquisition by Advent International, a global private equity firm. Advent International is now the promoter and a significant shareholder. The management team includes professionals with diverse experience, focusing on modernizing the company's operations, optimizing its sales channels, and enhancing profitability.
Outlook
Eureka Forbes holds a strong legacy and brand equity in the growing Indian health and hygiene appliance market. The market for water purifiers and air purifiers is driven by increasing health consciousness and disposable incomes, presenting a favorable long-term growth trajectory. However, the company operates in a highly competitive environment with both organized and unorganized players. Its ability to successfully transition and optimize its sales channels (balancing direct sales with modern retail and e-commerce), innovate its product portfolio, and improve operational efficiencies under the new ownership and management will be crucial for sustainable profitability and market leadership. The challenge lies in leveraging its strong brand and service network while adapting to changing consumer purchasing habits and intense market dynamics.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 539 | 554 | 553 | 673 | 598 | 613 | 608 | 772 | 645 | 684 |
| Other Income | 3 | 2 | 2 | 3 | 4 | 4 | 7 | 6 | 5 | 5 |
| Total Income | 542 | 555 | 556 | 677 | 602 | 617 | 615 | 778 | 651 | 689 |
| Total Expenditure | 497 | 500 | 497 | 600 | 539 | 536 | 546 | 674 | 577 | 598 |
| Operating Profit | 46 | 55 | 59 | 76 | 64 | 81 | 69 | 104 | 74 | 90 |
| Interest | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 3 | 2 |
| Depreciation | 13 | 14 | 14 | 14 | 15 | 15 | 16 | 16 | 17 | 20 |
| Exceptional Income / Expenses | 0 | -15 | 0 | 3 | 0 | 1 | 0 | 0 | -40 | 0 |
| Profit Before Tax | 31 | 24 | 43 | 64 | 47 | 66 | 52 | 85 | 14 | 69 |
| Provision for Tax | 8 | 3 | 11 | 16 | 12 | 17 | 13 | 22 | 4 | 18 |
| Profit After Tax | 23 | 21 | 32 | 48 | 35 | 49 | 39 | 63 | 10 | 51 |
| Adjustments | 0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 | 0 | 0 |
| Profit After Adjustments | 23 | 21 | 32 | 48 | 35 | 49 | 39 | 63 | 10 | 51 |
| Adjusted Earnings Per Share | 1.2 | 1.1 | 1.7 | 2.5 | 1.8 | 2.6 | 2 | 3.3 | 0.5 | 2.6 |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|
| Net Sales | 8 | 382 | 2085 | 2189 | 2437 | 2709 |
| Other Income | 0 | 3 | 10 | 9 | 15 | 23 |
| Total Income | 8 | 385 | 2095 | 2198 | 2452 | 2733 |
| Total Expenditure | 9 | 364 | 1939 | 1991 | 2172 | 2395 |
| Operating Profit | -1 | 21 | 155 | 207 | 280 | 337 |
| Interest | 0 | 4 | 20 | 10 | 6 | 8 |
| Depreciation | 0 | 9 | 56 | 54 | 58 | 69 |
| Exceptional Income / Expenses | 0 | 0 | -40 | -15 | 4 | -40 |
| Profit Before Tax | -2 | 7 | 39 | 128 | 221 | 220 |
| Provision for Tax | 0 | 4 | 12 | 33 | 56 | 57 |
| Profit After Tax | -2 | 3 | 26 | 96 | 164 | 163 |
| Adjustments | 0 | -0 | 0 | -0 | -0 | 0 |
| Profit After Adjustments | -2 | 3 | 27 | 96 | 164 | 163 |
| Adjusted Earnings Per Share | -3.4 | 0.1 | 1.4 | 4.9 | 8.5 | 8.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 11% | 85% | 0% | 0% |
| Operating Profit CAGR | 35% | 137% | 0% | 0% |
| PAT CAGR | 71% | 280% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -26% | -7% | NA% | NA% |
| ROE Average | 4% | 2% | -234% | -234% |
| ROCE Average | 5% | 3% | -15% | -15% |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Shareholder's Funds | 0 | 4076 | 4098 | 4226 | 4409 |
| Minority's Interest | 0 | 1 | 1 | 1 | 1 |
| Borrowings | 0 | 50 | 25 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 970 | 951 | 949 | 975 |
| Total Current Liabilities | 7 | 1030 | 955 | 952 | 952 |
| Total Liabilities | 7 | 6127 | 6029 | 6128 | 6337 |
| Fixed Assets | 0 | 5505 | 5481 | 5463 | 5471 |
| Other Non-Current Assets | 2 | 57 | 52 | 58 | 68 |
| Total Current Assets | 5 | 565 | 497 | 607 | 798 |
| Total Assets | 7 | 6127 | 6029 | 6128 | 6337 |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 18 | 19 | 61 |
| Cash Flow from Operating Activities | 0 | 37 | 181 | 194 | 246 |
| Cash Flow from Investing Activities | 0 | -4 | -26 | -32 | -168 |
| Cash Flow from Financing Activities | -0 | -31 | -154 | -120 | -43 |
| Net Cash Inflow / Outflow | -0 | 2 | 1 | 43 | 34 |
| Closing Cash & Cash Equivalent | 0 | 18 | 19 | 61 | 96 |
| # | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -3.38 | 0.13 | 1.37 | 4.94 | 8.5 |
| CEPS(Rs) | -3.08 | 0.61 | 4.29 | 7.74 | 11.5 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 0.29 | 210.67 | 211.79 | 216.62 | 224.94 |
| Core EBITDA Margin(%) | -16.84 | 4.63 | 6.96 | 9.07 | 10.86 |
| EBIT Margin(%) | -18.14 | 3.01 | 2.82 | 6.31 | 9.29 |
| Pre Tax Margin(%) | -20.68 | 1.85 | 1.85 | 5.87 | 9.06 |
| PAT Margin (%) | -20.78 | 0.69 | 1.27 | 4.37 | 6.75 |
| Cash Profit Margin (%) | -18.97 | 3.09 | 3.98 | 6.84 | 9.13 |
| ROA(%) | -22.82 | 0.09 | 0.44 | 1.57 | 2.64 |
| ROE(%) | -1175.41 | 0.13 | 0.65 | 2.31 | 3.85 |
| ROCE(%) | -86.88 | 0.53 | 1.38 | 3.26 | 5.23 |
| Receivable days | 109.6 | 72.97 | 23.99 | 21.77 | 23.79 |
| Inventory Days | 94.92 | 139.76 | 44.68 | 39.41 | 37.86 |
| Payable days | 255.69 | 255.04 | 94.1 | 82.63 | 68.25 |
| PER(x) | 0 | 2913.63 | 310.87 | 92.44 | 63.82 |
| Price/Book(x) | 0 | 1.86 | 2.01 | 2.11 | 2.41 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.74 | 20.42 | 4.01 | 4.01 | 4.2 |
| EV/Core EBITDA(x) | -4.53 | 377.22 | 53.82 | 42.27 | 36.55 |
| Net Sales Growth(%) | 0 | 4765.35 | 446.04 | 5.02 | 11.31 |
| EBIT Growth(%) | 0 | 906.54 | 411.82 | 135.23 | 63.71 |
| PAT Growth(%) | 0 | 260.41 | 912.25 | 261.32 | 71.89 |
| EPS Growth(%) | 0 | 103.98 | 922.04 | 260.13 | 71.9 |
| Debt/Equity(x) | 10.81 | 0.06 | 0.03 | 0.01 | 0 |
| Current Ratio(x) | 0.75 | 0.55 | 0.52 | 0.64 | 0.84 |
| Quick Ratio(x) | 0.46 | 0.27 | 0.29 | 0.37 | 0.57 |
| Interest Cover(x) | -7.17 | 2.6 | 2.9 | 14.14 | 40.21 |
| Total Debt/Mcap(x) | 0 | 0.03 | 0.01 | 0 | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 72.56 | 62.56 | 62.56 | 62.56 | 62.56 | 62.56 | 62.56 | 62.56 | 62.56 | 62.56 |
| FII | 10.77 | 16.01 | 13.21 | 12.62 | 12.56 | 12.53 | 14 | 13.71 | 13.87 | 13.66 |
| DII | 4.85 | 6.5 | 7.15 | 7.53 | 7.47 | 7.87 | 7.2 | 7.24 | 7.3 | 7.01 |
| Public | 11.82 | 14.93 | 17.09 | 17.29 | 17.41 | 17.04 | 16.24 | 16.49 | 16.27 | 16.77 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 14.04 | 12.1 | 12.1 | 12.1 | 12.1 | 12.1 | 12.1 | 12.1 | 12.1 | 12.1 |
| FII | 2.08 | 3.1 | 2.56 | 2.44 | 2.43 | 2.42 | 2.71 | 2.65 | 2.68 | 2.64 |
| DII | 0.94 | 1.26 | 1.38 | 1.46 | 1.44 | 1.52 | 1.39 | 1.4 | 1.41 | 1.36 |
| Public | 2.29 | 2.89 | 3.31 | 3.35 | 3.37 | 3.3 | 3.14 | 3.19 | 3.15 | 3.24 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19.35 | 19.35 | 19.35 | 19.35 | 19.35 | 19.35 | 19.35 | 19.35 | 19.35 | 19.35 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +11% | +85% | — | — |
| Operating Profit CAGR | +35% | +137% | — | — |
| PAT CAGR | +71% | +280% | — | — |
| Share Price CAGR | -26% | -7% | — | — |
| ROE Average | +4% | +2% | -234% | -234% |
| ROCE Average | +5% | +3% | -15% | -15% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 72.56 | 62.56 | 62.56 | 62.56 | 62.56 | 62.56 | 62.56 | 62.56 | 62.56 | 62.56 |
| FII | 10.77 | 16.01 | 13.21 | 12.62 | 12.56 | 12.53 | 14 | 13.71 | 13.87 | 13.66 |
| DII | 4.85 | 6.5 | 7.15 | 7.53 | 7.47 | 7.87 | 7.2 | 7.24 | 7.3 | 7.01 |
| Public | 27.44 | 37.44 | 37.44 | 37.44 | 37.44 | 37.44 | 37.44 | 37.44 | 37.44 | 37.44 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 14.04 | 12.1 | 12.1 | 12.1 | 12.1 | 12.1 | 12.1 | 12.1 | 12.1 | 12.1 |
| FII | 2.08 | 3.1 | 2.56 | 2.44 | 2.43 | 2.42 | 2.71 | 2.65 | 2.68 | 2.64 |
| DII | 0.94 | 1.26 | 1.38 | 1.46 | 1.44 | 1.52 | 1.39 | 1.4 | 1.41 | 1.36 |
| Public | 5.31 | 7.24 | 7.24 | 7.24 | 7.24 | 7.24 | 7.25 | 7.25 | 7.25 | 7.25 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19.35 | 19.35 | 19.35 | 19.35 | 19.35 | 19.35 | 19.35 | 19.35 | 19.35 | 19.35 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.